Author:
Pujol J.-L.,Breton J.-L.,Gervais R.,Rebattu P.,Depierre A.,Morère J.-F.,Milleron B.,Debieuvre D.,Castéra D.,Souquet P.-J.,Moro-Sibilot D.,Lemarié E.,Kessler R.,Janicot H.,Braun D.,Spaeth D.,Quantin X.,Clary C.
Reference29 articles.
1. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997, by the American Society of Clinical Oncology;American Society of Clinical Oncology;J Clin Oncol,1997
2. The expanding role of cisplatin in the treatment of non-small-cell lung cancer;Bunn;Semin Oncol,1989
3. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials;Non-small Cell Lung Cancer Collaborative Group;BMJ,1995
4. Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer;Sandler;J Clin Oncol,2000
5. Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study;Wozniak;J Clin Oncol,1998
Cited by
111 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献